Related Experiment Video

Updated: Jul 20, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Sphingolipids as modulators of cancer cell death: potential therapeutic targets

Bruno Ségui1, Nathalie Andrieu-Abadie, Jean-Pierre Jaffrézou

  • 1INSERM U.466, Laboratoire de Biochimie, Institut Louis Bugnard, Centre Hospitalier Universitaire de Rangueil, BP 84225, 31432 Toulouse Cedex 4, France.

Biochimica Et Biophysica Acta
|August 24, 2006
PubMed

Insights

Sphingolipids influence cancer cell growth, apoptosis, and resistance to therapy. Manipulating sphingolipid metabolism offers potential new anticancer treatments targeting tumor development and cell death.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Sphingolipids, including ceramide and its metabolites, play crucial roles in cellular processes.
  • These lipids impact cell-cell and cell-matrix interactions, and intracellular signaling pathways.
  • Dysregulation of sphingolipid metabolism is implicated in various diseases, including cancer.

Purpose of the Study:

  • To review the current understanding of sphingolipid functions in cancer.
  • To explore the role of sphingolipids in regulating cancer cell death and tumor progression.
  • To discuss the therapeutic potential of targeting sphingolipid metabolism in cancer treatment.

Main Methods:

  • Literature review of existing research on sphingolipids and cancer.
  • Analysis of studies investigating sphingolipid effects on cell growth, apoptosis, and drug resistance.
  • Synthesis of information regarding therapeutic strategies involving sphingolipid modulation.

Main Results:

  • Sphingolipids significantly affect tumorigenic potential by altering membrane structure and signaling.
  • Ceramide and other sphingolipids regulate cancer cell survival, apoptosis, and resistance to anticancer drugs.
  • Sphingolipids can influence susceptibility to non-apoptotic cell death pathways in malignant cells.

Conclusions:

  • Sphingolipids are key regulators of cancer cell death and tumor development.
  • Targeting sphingolipid metabolism presents promising avenues for novel anticancer therapies.
  • Sphingolipid analogues may be utilized to enhance treatment efficacy and overcome drug resistance.

More Related Videos

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...